Analyst Reco. Core Laboratories Inc.

Equities

CLB

US21867A1051

Real-time Estimate Cboe BZX Other stock markets 10:47:28 2024-04-26 am EDT			5-day change	1st Jan Change
17.34 ^USD	+1.61%		+0.52%	-2.21%

Apr. 25	Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024
Apr. 24	Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	Jan. 29	MT
Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	23-09-18	MT
Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	23-07-31	MT
Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	23-06-30	MT
Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	23-05-01	MT
Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	23-05-01	MT
Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	23-04-28	MT
BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	23-04-18	MT
Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	23-02-07	MT
BofA Securities Upgrades Core Laboratories to Neutral From Underperform	23-01-09	MT
Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	22-10-07	MT
Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	22-09-26	MT
Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	22-08-02	MT
Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	22-08-01	MT
BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	22-07-15	MT
Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	22-07-13	MT
Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	22-07-13	MT
Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	22-05-02	MT
Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	22-04-18	MT
Morgan Stanley Adjusts Core Laboratories' Price Target to $35 from $30, Keeps Equalweight Rating	22-04-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Core Laboratories Inc.

Equities

CLB

US21867A1051

Analyst Reco.

Filters